Drug From Genentech and Biogen Fails as a Lupus Treatment
Thursday, May 1, 2008 - 20:28
in Health & Medicine
The companies said that their drug Rituxan did not achieve any of seven measures of effectiveness in a late-stage patient trial.
Read the whole article on NY Times Health
More from NY Times Health
Related
- Rituximab reduces kidney inflammation in patients with lupusWed, 4 Mar 2009, 18:44:05 EST
- National report shines light on lupus 50-year treatment droughtMon, 5 Oct 2009, 2:14:46 EDT
- Promising early evidence of the superior benefits of drug therapy for diabetic eye diseaseWed, 30 Apr 2008, 14:58:02 EDT
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- HIV integrase inhibitor effective for patients beginning antiretroviral treatmentSun, 2 Aug 2009, 19:42:37 EDT